Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Hylek

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinics in Geriatric Medicine|March 29, 2001
Oral anticoagulants. Pharmacologic issues for use in the elderlyE M Hylek
Annals of Internal Medicine|June 1, 1994
Risk factors for intracranial hemorrhage in outpatients taking warfarinE M Hylek, D E Singer
Journal of Thrombosis and Haemostasis : JTH|December 24, 2010
Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratificationK P Cabral, J Ansell, E M Hylek
Neurology|November 4, 2000
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic studyJ Rosand, E M Hylek, H C O'Donnell, et al.
Thrombosis and Haemostasis|December 22, 2009
Anticoagulation for valvular heart disease in community-based practiceA J Rose, A Ozonoff, L E Henault, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2008
Warfarin for atrial fibrillation in community-based practiseA J Rose, A Ozonoff, L E Henault, et al.
The New England Journal of Medicine|August 22, 1996
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillationE M Hylek, S J Skates, M A Sheehan, et al.
Neurology|July 24, 2002
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic strokeE E Smith, J Rosand, K A Knudsen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Warfarin dose management affects INR controlA J Rose, A Ozonoff, D R Berlowitz, et al.
JAMA|March 13, 1998
Acetaminophen and other risk factors for excessive warfarin anticoagulationE M Hylek, H Heiman, S J Skates, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinics in Geriatric Medicine|March 29, 2001
Oral anticoagulants. Pharmacologic issues for use in the elderlyE M Hylek
Annals of Internal Medicine|June 1, 1994
Risk factors for intracranial hemorrhage in outpatients taking warfarinE M Hylek, D E Singer
Journal of Thrombosis and Haemostasis : JTH|December 24, 2010
Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratificationK P Cabral, J Ansell, E M Hylek
Neurology|November 4, 2000
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic studyJ Rosand, E M Hylek, H C O'Donnell, et al.
Thrombosis and Haemostasis|December 22, 2009
Anticoagulation for valvular heart disease in community-based practiceA J Rose, A Ozonoff, L E Henault, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2008
Warfarin for atrial fibrillation in community-based practiseA J Rose, A Ozonoff, L E Henault, et al.
The New England Journal of Medicine|August 22, 1996
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillationE M Hylek, S J Skates, M A Sheehan, et al.
Neurology|July 24, 2002
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic strokeE E Smith, J Rosand, K A Knudsen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Warfarin dose management affects INR controlA J Rose, A Ozonoff, D R Berlowitz, et al.
JAMA|March 13, 1998
Acetaminophen and other risk factors for excessive warfarin anticoagulationE M Hylek, H Heiman, S J Skates, et al.
Pageof 3